Amylin

Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg
Wed, 02/2/11 - 08:42 am
Sanofi
diabetes
Byetta
lixisenatide
Amylin
Eli Lilly
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
Amylin takes smaller 4Q loss as expenses decline
Yahoo/AP
Thu, 01/27/11 - 11:30 am
Amylin
earnings
Alkermes
Timing Positive For Bydureon
Forbes
Wed, 01/26/11 - 08:38 pm
Bydureon
FDA
Amylin
QT intervals
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Lexicon Pharmaceuticals
diabetes
LX4211
Merck
obesity
Amylin
Januvia
Onglyza
Bristol-Myers Squibb
AstraZeneca
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Amylin Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Seeking Alpha
Mon, 11/8/10 - 09:37 am
Amylin
earnings
FDA Ends October With Drug Approvals, Rejection
TheStreet.com
Mon, 11/1/10 - 08:59 am
FDA
Biodel
Avanir
Forest Labs
Arena Pharmaceuticals
Vivus
Amylin
Questcor Pharmaceuticals
Alkermes
Biotech ETFs Up As Biogen, Illumina, Amylin Soar
Barron's
Wed, 10/27/10 - 09:08 pm
Biogen Idec
Amylin
Illumina
ETFs
Amylin Pharmaceuticals: Will it Navigate the Rough Waters Ahead?
Seeking Alpha
Tue, 10/26/10 - 11:54 am
Amylin
diabetes
exanitide
Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Bloomberg
Sat, 10/23/10 - 12:39 pm
Eli Lilly
diabetes
Amylin
Pfizer
Sanofi
Cephalon
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Bloomberg
Fri, 10/22/10 - 07:26 am
diabetes
Amylin
Eli Lilly
Cephalon
M&A
Endo
Bydureon
Byetta
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Amylin
diabetes
Alkermes
Eli Lilly
Bydureon
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Alkermes
FDA
Bydureon
diabetes
Eli Lilly
Amylin
Byetta
Vivitrol
alcoholism
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thu, 10/14/10 - 09:29 am
FDA
Hospira
Human Genome Sciences
Alexza
Jazz Pharmaceuticals
Alkermes
Arena Pharmaceuticals
Amylin
Vivus
Avanir
Forest Labs
Biodel
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
BNET Pharma
Mon, 10/11/10 - 05:55 pm
Meridia
diet drugs
Abbott Laboratories
GSK
Roche
Allergan
Novo Nordisk
Sanofi
Merck
Eli Lilly
Amylin
Takeda
Orexigen
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb

Pages